DELIVERY ORDER
ExpiredHT001426FE073
Department of Defense › Defense Health Agency › DEFENSE HEALTH AGENCY
$501.7K
obligated · signed 4 months ago
PROCURE RADIOPHARMACEUTICAL PRODUCTS
Performance timeline
Start
Jul 9, 2026
End
Jul 9, 2026
with all options
Loading status
This contract has expired. A follow-on may have been awarded.
Search for new solicitations from Department of Defense.
NOVARTIS PHARMACEUTICALS CORPORATION
Contract HT001426FE073
UEI
NG61ZA8TADW3
Parent Company
NOVARTIS SANIERUNGSSTIFTUNG
Capabilities & Certifications
Headquarters Location
Congressional District: 11
Current Obligation
$501,670
Base + Exercised Options
$501,670
Total Ceiling Value
$501,670
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Place of Performance
Congressional District: 08
Awarding Agency
Funding Agency
Contract Vehicle
36F79720D0180
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.